- Membre: 13619$
Includes new chapters on cannabis; psychedelics such as psilocybin, MDMA, and ketamine; and genetics and the role of pharmacogenomics testing, brain stimulation, and other novel technologies in psychiatry
Includes many new FDA-approved drugs, as well as updated information about drug selection and use that reflects both research data and clinical experience
Addresses the complex relationship between the use of psychotropic medicines and medical comorbidities, including metabolic complications, with emphasis on recognition, investigations, treatment, and management
Features a new, full-color format with color icons that highlight side effects, notable benefits, and other important indications for each drug
Provides a wealth of data for each drug: chemical name; preparation and dosages; pharmacologic actions; indications for use and clinical applications; use in children, elderly persons, and pregnant and nursing women; side effects and adverse and allergic reactions; and drug-drug interactions
Ideal for psychiatrists and other physicians, as well as psychiatric residents, medical students, clinical psychologists, psychiatric nurses, and other professionals who provide care for patients with mental illness
Enrich Your eBook Reading Experience
Read directly on your preferred device(s), such as computer, tablet, or smartphone.
Easily convert to audiobook, powering your content with natural language text-to-speech.
- Code produit272486
- ÉditeurLIPPINCOTT (LOGIN)
- Date de publication31 juillet 2023
Disponible dans les succursales suivantes
L’inventaire et le prix sont sujets à changement. Nous vous suggérons de contacter Coop Zone avant de vous déplacer:
Maurice-PollackLocalisation : L12A312